Organogenesis: Difference between revisions
WikiModEn2 (talk | contribs) m →Call for increase of foreskin harvesting: Wikify. |
WikiModEn2 (talk | contribs) →Apligraph Oral: Update URL. |
||
| (One intermediate revision by the same user not shown) | |||
| Line 35: | Line 35: | ||
== Apligraph Oral == | == Apligraph Oral == | ||
Organogenesis is presently seeking [[FDA]] approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."<ref>{{REFweb | Organogenesis is presently seeking [[FDA]] approval for Apligraph Oral, a [[foreskin]]-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."<ref>{{REFweb | ||
|last= | |last= | ||
|first= | |first= | ||
|date=2011-11-17 | |date=2011-11-17 | ||
|title=November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript | |title=November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript | ||
|url= | |url=https://www.fda.gov/advisory-committees/advisory-committee-calendar/cellular-tissue-and-gene-therapies-advisory-committee-september-2-3-2021-meeting-announcement | ||
|publisher= | |publisher= | ||
|accessdate= | |accessdate=2021-09-02 | ||
}}</ref> | }}</ref> | ||
| Line 48: | Line 48: | ||
[[Category:Company]] | [[Category:Company]] | ||
[[Category:Financial gain]] | |||
[[Category:Foreskin product]] | |||
[[Category:From CircLeaks]] | [[Category:From CircLeaks]] | ||